Upgrade to SI Premium - Free Trial

Omeros (OMER)

9.48 +0.15 (1.61%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Omeros Announces Webcast Details for Annual Meeting of Shareholders June 15, 2026 8:30 AM - BizWire Increasing unusual put option volume: SPCE FITB OMER BIRK TRIP SATS PURR June 15, 2026 6:24 AM - StreetInsider Increasing unusual put volume: OMER TRIP SPCE PURR BIRK XP June 12, 2026 11:38 AM - StreetInsider Increasing unusual call OMER TRIP SPCE PURR XP June 12, 2026 11:25 AM - StreetInsider Omeros (OMER) Halted on Circuit Volatility, Down 22% June 12, 2026 9:48 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Omeros Corp. (OMER) June 10, 2026 7:12 AM - StreetInsider Form 4 OMEROS CORP For: May 22 Filed by: Cable Thomas J. May 27, 2026 6:21 PM - SEC Filing Form 144 OMEROS CORP Filed by: Cable Thomas J. May 22, 2026 4:34 PM - SEC Filing Omeros (OMER) Misses Q1 EPS by 12c May 13, 2026 4:19 PM - StreetInsider Omeros (OMER) Misses Q1 EPS by 12c May 13, 2026 4:11 PM - StreetInsider Form 10-Q OMEROS CORP For: Mar 31 May 13, 2026 4:08 PM - SEC Filing Form 8-K OMEROS CORP For: May 13 May 13, 2026 4:08 PM - SEC Filing Omeros Corporation Reports First Quarter 2026 Financial Results May 13, 2026 4:02 PM - BizWire Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026 May 11, 2026 4:02 PM - BizWire Form ARS OMEROS CORP For: Dec 31 April 30, 2026 8:04 AM - SEC Filing Form DEF 14A OMEROS CORP For: Jun 18 April 30, 2026 8:03 AM - SEC Filing Form SCHEDULE 13G/A OMEROS CORP Filed by: INGALLS & SNYDER LLC April 23, 2026 10:09 AM - SEC Filing Sagimet Biosciences names Andreas Grauer as chief medical officer April 20, 2026 7:01 AM - StreetInsider Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer April 20, 2026 7:00 AM - Globe NewsWire CMS assigns permanent J-code for Omeros' YARTEMLEA drug treatment April 16, 2026 8:50 AM - StreetInsider CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug) April 16, 2026 8:49 AM - BizWire Omeros (OMER) Tops Q4 EPS by 366c March 31, 2026 4:10 PM - StreetInsider Form 10-K OMEROS CORP For: Dec 31 March 31, 2026 4:08 PM - SEC Filing Form 8-K OMEROS CORP For: Mar 31 March 31, 2026 4:07 PM - SEC Filing Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results March 31, 2026 4:02 PM - BizWire Form SCHEDULE 13G/A OMEROS CORP Filed by: VANGUARD GROUP INC March 27, 2026 11:06 AM - SEC Filing Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026 March 26, 2026 8:45 AM - BizWire Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment March 21, 2026 3:24 AM - BizWire Full Article List